NEW YORK (GenomeWeb News) – Temis, a semantic solutions provider, has acquired i3 Analytics, a developer of data analytics and visualization technologies for the life sciences, for an undisclosed amount.
According to Temis, the acquisition adds a complementary solution to its existing product portfolio and brings in additional technical know-how to the company that should help expand its life sciences footprint.
I3 Analytics markets Biopharma Navigator, a software-as-a-service platform that provides users with tools to explore and visualize the biopharmaceutical landscape. It gives users access to information that helps them make informed clinical, regulatory, and business decisions.
Temis intends to integrate Biopharma Navigator into Luxid, its flagship platform for identifying and extracting information used to semantically enrich customers' content, and make it available for a variety of applications.